Study Condition(s): Mild Alzheimer's, Mild Cognitive Impairment

A Study of Lanabecestat (LY3314814) in Participants With Early Alzheimer's Disease Dementia

Study Alias: AZFD

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02972658 {{ currentLocaleObject.registryAnchorText }}

Terminated Terminated

Study Purpose

This study is an extension of study I8D-MC-AZES (NCT02245737), the AMARANTH study. The purpose of this study is to evaluate the effectiveness of the study drug LY3314814 in participants with early Alzheimer's disease dementia at the time of entry into study I8D-MC-AZES.

Terminated Study

This trial stopped recruiting or enrolling participants prematurely and will not start again. We are no longer examining or treating participants. The trial may have been stopped for many reasons. You may contact Lilly for further information.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

55+ years

Time Commitment

Your participation could last up to 56 weeks and include at least 13 visits to the study center.
  • Participants must have been previously enrolled in AMARANTH (NCT02245737) study

Where This Study Took Place Tool Tip Icon

209 locations participated
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.